Novel approach to specific growth factor inhibition in vivo: antagonism of platelet-derived growth factor in glomerulonephritis by aptamers.
about
Gas6 regulates mesangial cell proliferation through Axl in experimental glomerulonephritisFrom selection hits to clinical leads: progress in aptamer discoveryMolecular Selection, Modification and Development of Therapeutic Oligonucleotide AptamersNucleic Acid aptamers: new methods for selection, stabilization, and application in biomedical scienceVEGF(165) mediates glomerular endothelial repairFit for the Eye: Aptamers in Ocular DisordersIn vitro RNA SELEX for the generation of chemically-optimized therapeutic RNA drugsRole of platelet-derived growth factors in physiology and medicineNucleic acid aptamers in cancer medicine.The rapamycin derivative RAD inhibits mesangial cell migration through the CDK-inhibitor p27KIP1.Mechanisms of everolimus-induced glomerulosclerosis after glomerular injury in the rat.Inhibition of the in vitro replication of DNA by an aptamer-protein complex in an autonomous DNA machine.Development of DNA aptamers using Cell-SELEX.Rationales for treating IgA nephropathies.Refilling drug delivery depots through the blood.Anti-heparanase aptamers as potential diagnostic and therapeutic agents for oral cancer.Development of novel single-stranded nucleic acid aptamers against the pro-angiogenic and metastatic enzyme heparanase (HPSE1)TLR agonists regulate PDGF-B production and cell proliferation through TGF-beta/type I IFN crosstalk.Targeting the PDGF signaling pathway in the treatment of non-malignant diseases.Potential methods to prevent interstitial fibrosis in renal disease.The effects of PTK787/ZK222584, an inhibitor of VEGFR and PDGFRβ pathways, on intussusceptive angiogenesis and glomerular recovery from Thy1.1 nephritis.Biophysical characterization of DNA aptamer interactions with vascular endothelial growth factor.Tyrosine kinases inhibition by Imatinib slows progression in chronic anti-thy1 glomerulosclerosis of the ratIn vivo imaging with oligonucleotides for diagnosis and drug development.Platelet-derived growth factor as a therapeutic target for systemic autoimmune diseases.Targeting pericytes with a PDGF-B aptamer in human ovarian carcinoma models.Neutralization of staphylococcal enterotoxin B by an aptamer antagonistNucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic AgentsRational truncation of an RNA aptamer to prostate-specific membrane antigen using computational structural modeling.Nucleic acid aptamers as tools and drugs: recent developments.Estimated glomerular filtration rate changes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitorsPrediction of aptamer-protein interacting pairs using an ensemble classifier in combination with various protein sequence attributesHepatic tumor growth: target for angiogenesis inhibition?Aptamers--basic research, drug development, and clinical applications.Noncoding RNAs in cancer medicineResveratrol inhibits PDGF receptor mitogenic signaling in mesangial cells: role of PTP1B.Forty years of in vitro evolution.Therapeutic applications of aptamers.Selection and characterization of single stranded DNA aptamers for the hormone abscisic Acid.Inhibition of ghrelin action in vitro and in vivo by an RNA-Spiegelmer.
P2860
Q24672961-648FEFC7-5952-4460-A1D4-2F10EDABF576Q26752799-0F4B6DFF-3096-4368-A9F4-BBF945EDAB9CQ26765458-F8898ADC-4684-46CC-96CF-32EE20295653Q26995510-E0D27F10-F9B4-425E-8807-E200BBA36384Q28343621-CA4E4464-0503-4556-A052-9C19FC619549Q28828283-A6E046AA-CD21-4206-A38A-B1B678E03DF2Q28828886-DE0720EA-2F0A-4FCA-942A-F0C1F25F2D67Q29615222-9F8DB2A6-6E32-4580-902C-3717737C299FQ30854890-BF82621F-8AC4-41E7-9804-902309571E99Q33200968-C8B47550-A199-45BE-8253-7DAB5716CA6FQ33227653-AF144F01-3C4E-404B-93E2-353410893B88Q33506454-0022019E-4E69-481C-A375-A868774A8C0CQ33600982-C6BFEA59-3005-4FCA-B11B-CDF47473E47DQ33863555-E86CB573-9848-4A5E-A5E8-9A39FAFC4E30Q34144515-CC4D7D03-20A9-434F-A55E-65F39EF47C33Q34306827-9ED75E4A-444B-4DDE-9ED0-5BBD579A6AC0Q34311783-F12D38D0-3B22-4721-82A8-03504C8CA12CQ34324873-2D91C286-51F8-4D92-8CFA-A928F8BE59A6Q34352802-E2938612-7F02-484B-80EE-AD9EE5B9C2C1Q34481843-28CEDDEA-79F8-4D38-8CCB-B51B9CE91AAAQ34805455-459698E7-41A8-4A16-B4AF-8C610651C7BDQ34886159-F2271C2A-C725-494A-AED9-6D300FCF243EQ35015952-1BD84B33-4972-4501-8CCA-7FC34691C24CQ35127223-62BEC958-46D5-47ED-AA26-BAD289E3551DQ35161761-8EA4A860-2E4B-44D0-8503-CFF4FC66C113Q35163538-08C27DAE-323F-4CD9-AAD4-74BCD93FB103Q35169108-9EFFA9C8-B763-4AB9-A2F1-6CE52E962C37Q35309726-D88BC889-61DA-42AA-97C6-C5EAD50D2C5FQ35413768-238E4A25-55F9-4035-A264-BE026A51F5B0Q35549348-AFC4B687-3B04-42A4-A2E2-96E380028F51Q35902738-9E356665-BC8D-4150-82BB-3D533E642C3FQ36034999-982A53D7-5D2E-45B1-90AD-87F084609A59Q36038489-C6A4C28A-A4DD-4948-B781-6EC73CAF46BBQ36311540-0B9637F8-898D-4C0D-BC76-FCF273B7C30EQ36631543-B583F592-A4E4-48AA-9FB6-7CF7DBA3A04BQ36879390-9F222E54-9720-4715-BE5E-D79007CC182CQ36883743-010F2DDC-912B-4642-B4F3-EC11DEEA8419Q37038988-0CDA8AF4-3D83-4E73-8D10-C66F484BC6CAQ37139585-916FEFCF-CBC7-4252-9FCF-7C54FDC78918Q37513215-2A7296FF-EC3E-436D-8518-831DCD5B0BD8
P2860
Novel approach to specific growth factor inhibition in vivo: antagonism of platelet-derived growth factor in glomerulonephritis by aptamers.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Novel approach to specific gro ...... lomerulonephritis by aptamers.
@en
Novel approach to specific gro ...... lomerulonephritis by aptamers.
@nl
type
label
Novel approach to specific gro ...... lomerulonephritis by aptamers.
@en
Novel approach to specific gro ...... lomerulonephritis by aptamers.
@nl
prefLabel
Novel approach to specific gro ...... lomerulonephritis by aptamers.
@en
Novel approach to specific gro ...... lomerulonephritis by aptamers.
@nl
P2093
P2860
P1476
Novel approach to specific gro ...... glomerulonephritis by aptamers
@en
P2093
C Vargeese
T Ostendorf
P2860
P304
P356
10.1016/S0002-9440(10)65263-7
P407
P577
1999-01-01T00:00:00Z